Leukocyte-poor CPD blood.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
We studied complement functions, breakdown of C3 and aggregation of immunoglobulins in whole blood stored in citrate phosphate dextrose at 4 degrees C for up to 3 weeks from 10 normal blood donors. No significant changes in total haemolytic complement (CH50) and alternative pathway haemolytic complement activity were detected. However, the complement-mediated capacity of the sera to solubilise a pre-formed immune precipitate decreased significantly at 2 and 3 weeks (p less than 0.02 at 2 weeks, p less than 0.003 at 3 weeks). No C3 conversion could be detected by immunoelectrophoresis but alteration in C3 was attested by a significant increase in breakdown products of C3 by 1 week (p less than 0.002) and all were above the normal range after 3 weeks (p less than 0.0001). No aggregation of immunoglobulins could be detected using two immune complex assays.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.